Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.82
-0.65 (-2.46%)
At close: Apr 28, 2026, 4:00 PM EDT
25.95
+0.13 (0.50%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.43 billion as of April 28, 2026. Its market cap has increased by 318.08% in one year.
Market Cap
1.43B
Enterprise Value
1.12B
1-Year Change
318.08%
Ranking
Category
Stock Price
$25.82
Market Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.43B, an increase of 109.23%. That is a compound annual growth rate of 81.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 1.43B | -28.08% |
| Dec 31, 2025 | 1.99B | 190.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Damora Therapeutics | 1.54B |
| Immatics | 1.52B |
| MBX Biosciences | 1.52B |
| Bicara Therapeutics | 1.47B |
| Ardelyx | 1.47B |
| Immunocore Holdings | 1.45B |
| Biohaven | 1.44B |
| Agios Pharmaceuticals | 1.43B |